Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Income towards Parent Company: 2016-2021

Historic Income towards Parent Company for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$3.1 million.

  • ENDRA Life Sciences' Income towards Parent Company fell 37.94% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 4.22%. This contributed to the annual value of -$11.5 million for FY2024, which is 14.39% down from last year.
  • Per ENDRA Life Sciences' latest filing, its Income towards Parent Company stood at -$3.1 million for Q4 2021, which was down 16.79% from -$2.7 million recorded in Q3 2021.
  • ENDRA Life Sciences' 5-year Income towards Parent Company high stood at -$741,623 for Q1 2017, and its period low was -$4.8 million during Q4 2019.
  • For the 3-year period, ENDRA Life Sciences' Income towards Parent Company averaged around -$3.0 million, with its median value being -$3.0 million (2020).
  • Its Income towards Parent Company has fluctuated over the past 5 years, first crashed by 280.96% in 2018, then soared by 53.20% in 2020.
  • ENDRA Life Sciences' Income towards Parent Company (Quarterly) stood at -$2.3 million in 2017, then declined by 3.09% to -$2.4 million in 2018, then crashed by 103.30% to -$4.8 million in 2019, then soared by 53.20% to -$2.3 million in 2020, then tumbled by 37.94% to -$3.1 million in 2021.
  • Its last three reported values are -$3.1 million in Q4 2021, -$2.7 million for Q3 2021, and -$3.2 million during Q2 2021.